Brinker International and Corcept Therapeutics to move to S&P MidCap 40
Brinker International and Corcept Therapeutics are moving from S&P SmallCap 600 to S&P MidCap 40.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.